Rheumatoid arthritis (RA) is a serious autoimmune disease, but how bad it gets depends heavily on when it’s caught and how it’s treated. Left unchecked, it can destroy joints permanently and affect organs throughout the body. With modern treatment, though, roughly 89% of patients on biologic therapies achieve remission within five years. The gap between the best and worst outcomes is enormous, which is why understanding what RA actually does to the body matters so much.
What RA Does to Your Joints
RA isn’t like the wear-and-tear arthritis (osteoarthritis) that develops with age. It’s your immune system attacking your own joint lining. Normally, the tissue lining your joints is only one to two cells thick. In RA, that lining swells to eight to ten cells thick, packed with immune cells, and begins growing new blood vessels to feed the inflamed tissue. This overgrown tissue, called pannus, physically invades and erodes the cartilage and bone underneath.
The destruction happens through two pathways at once. Inflammatory signals drive enzymes that break down cartilage while simultaneously blocking the body’s ability to repair it. Meanwhile, those same signals activate bone-destroying cells called osteoclasts, which eat away at the bone itself. The result is permanent structural damage: joints lose their cushioning, their shape changes, and they can eventually fuse or collapse. This process begins early. The damage that occurs in the first two years is often irreversible, which is why rheumatologists push for aggressive treatment as soon as possible.
How It Feels Day to Day
The hallmark of RA is morning stiffness that lasts well over 30 minutes, often an hour or more. This is a key difference from osteoarthritis, where stiffness typically loosens up within 15 to 30 minutes of moving around. RA stiffness can leave your hands so rigid in the morning that opening a jar or gripping a toothbrush feels impossible.
Beyond stiffness, RA causes joint swelling, warmth, and deep aching pain that tends to affect both sides of the body symmetrically. It often starts in the small joints of the hands and feet before moving to larger joints like the wrists, knees, and shoulders. Fatigue is another major symptom that people underestimate. The chronic inflammation drains energy in a way that sleep doesn’t fix, and many people describe it as the most disabling part of the disease.
Effects Beyond the Joints
RA is a systemic disease, meaning it doesn’t stay in the joints. The same inflammatory process that destroys cartilage and bone circulates through the bloodstream and can damage organs throughout the body.
The heart is a major concern. Atherosclerosis (hardening and blockage of arteries) is the most common cardiovascular complication in RA and the leading cause of death among RA patients. Chronic, body-wide inflammation accelerates plaque buildup in blood vessels. RA also raises the risk of inflammation in the sac surrounding the heart.
The lungs are another target. RA can cause inflammation and scarring of lung tissue (interstitial lung disease), fluid buildup around the lungs, and nodules within the lung itself. Pulmonary function tests in RA patients commonly show reduced lung capacity. Respiratory diseases, particularly pneumonia and interstitial lung disease, are significantly elevated causes of death in people with RA.
About 10 to 15% of RA patients develop a secondary condition that reduces moisture production in the eyes and mouth, causing chronic dry eyes, dry mouth, and an increased risk of eye surface damage. More serious eye complications like deep inflammation of the white of the eye are rare but can threaten vision. Firm tissue lumps called rheumatoid nodules can also form around pressure points like the elbows, and in some cases develop in the heart or lungs.
Impact on Work and Independence
The functional toll of RA is steep. One in five people with RA is unable to work within two years of diagnosis. Within five years, that number rises to one in three. These aren’t just people in physically demanding jobs. RA affects fine motor skills, grip strength, and stamina in ways that make desk work, driving, and household tasks difficult too.
Simple activities like buttoning a shirt, turning a key, or climbing stairs can become genuinely painful challenges during flares. Over time, joint damage can make some of these limitations permanent even when inflammation is controlled. This is a large part of why early treatment matters so much: preventing joint destruction preserves function in ways that can’t be recovered later.
Does RA Shorten Your Life?
Historically, RA carried a significant mortality risk. Modern data paints a more reassuring picture. A study published in Rheumatology (Oxford) found that the overall reduction in life expectancy for RA patients was about four months over a 20-year period. That’s a meaningful improvement over older estimates, likely reflecting better treatments and earlier intervention.
The causes of death in RA patients do differ from the general population in important ways, though. Respiratory diseases, especially pneumonia and interstitial lung disease, carry a dramatically higher risk. Interestingly, coronary heart disease and cancer rates in the same study were not significantly elevated compared to the general population. RA itself was frequently listed as an underlying cause of death, reflecting the cumulative burden of the disease on the body.
How Treatment Changes the Outlook
The difference between treated and untreated RA is dramatic. Before modern disease-modifying drugs existed, RA was often a path toward severe disability and joint deformity. Today, the standard approach uses medications that suppress the overactive immune response, and the results are striking.
In a real-world study of 747 patients treated with biologic therapies under a targeted strategy, 89% achieved remission by the five-year mark. At the start of that study, more than half the patients had moderate disease activity and a quarter had high disease activity. Remission doesn’t always mean the disease is gone entirely, but it means inflammation is controlled enough that joint damage slows or stops and symptoms become manageable.
The critical factor is timing. RA treatment follows what rheumatologists call a “window of opportunity” in the first months after symptoms begin. Starting treatment early, before significant joint erosion occurs, gives patients the best chance of preserving joint function and reaching remission. People who delay treatment by even a year face measurably worse long-term outcomes in terms of both joint damage and disability. The disease is still serious, but for most people, it’s no longer the crippling condition it was a generation ago.